BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10151281)

  • 1. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of the pharmacist in reporting adverse drug reactions in the emergency department.
    Ratz Y; Shafir I; Berkovitch S; Sharristh M; Jacoby M; Kozer E; Golik A; Berkovitch M; Bar-Haim S
    J Clin Pharmacol; 2010 Oct; 50(10):1217-21. PubMed ID: 20418507
    [No Abstract]   [Full Text] [Related]  

  • 3. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a more formal adverse drug reaction reporting system.
    Tse CS; Madura AJ
    Hosp Formul; 1992 Aug; 27(8):845-8. PubMed ID: 10119518
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical pharmacist as a member of the burn team.
    Anderson PO; Wachtel TL; Frank HA; Trubo BG
    Contemp Pharm Pract; 1982; 5(2):120-3. PubMed ID: 10256910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy protocol for adjusting patient-controlled analgesia.
    Berggren P; Matsuoka R
    Hosp Pharm; 1990 Oct; 25(10):928-9, 932. PubMed ID: 10107395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting up an automatic pharmacist-initiated pharmacokinetic dosing service.
    Ament PW; McGuire WM
    Hosp Formul; 1993 Jun; 28(6):589-92. PubMed ID: 10126587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.
    Nazario M; Feliú JF; Rivera GC
    Hosp Pharm; 1994 Mar; 29(3):244-6, 249-50. PubMed ID: 10171808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of a computerized adverse drug event monitor using a hospital information system.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    Hosp Pharm; 1992 Sep; 27(9):774, 776-9, 783. PubMed ID: 10121426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist empowerment: taking practice guidelines to the next level (Part 2).
    Puckett W; Egle L; Galt M
    Hosp Formul; 1994 Nov; 29(11):767-72. PubMed ID: 10138573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.